Taclonex Dosing and Supply for Scalp Psoriasis
For scalp psoriasis, apply Taclonex Topical Suspension (calcipotriene 0.005%/betamethasone dipropionate 0.064%) once daily for 4-12 weeks, with a maximum weekly dose of 100 grams for adults (18+ years) or 60 grams for adolescents (12-17 years), and the product is supplied in 60-gram bottles or 120-gram packages (two 60-gram bottles). 1
Dosing Schedule
Application Frequency and Duration
- Once daily application to affected scalp areas 1
- Treatment duration: 4-12 weeks as recommended by AAD-NPF guidelines 2
- Discontinue when control is achieved unless directed otherwise by your healthcare provider 1
Maximum Weekly Doses
- Adults (≥18 years): 100 grams per week maximum 1
- Adolescents (12-17 years): 60 grams per week maximum 1
These dose limits are critical to avoid systemic absorption and potential adverse effects including hypercalcemia and HPA axis suppression 1.
How Supplied
Taclonex Topical Suspension is available in:
- 60-gram bottle (NDC 50222-501-06) 1
- 120-gram package containing two 60-gram bottles (NDC 50222-501-66) 1
Storage Requirements
- Store at room temperature 68°F-77°F (20°C-25°C) 1
- Do not refrigerate 1
- Keep bottle in carton when not in use 1
- Discard unused product 6 months after opening 1
- Shake bottle before each use 1
Application Technique for Scalp
The FDA label provides specific instructions 1:
- No need to wash hair before application
- Shake the bottle before use
- Part hair to locate affected areas
- Squeeze a drop onto fingertip
- Apply directly to affected scalp areas and gently rub in
- Replace cap after application
- Wash hands after applying
- Do not wash hair immediately after application
Evidence Supporting This Recommendation
The 2021 AAD-NPF guidelines provide Grade A evidence (strongest recommendation) for using calcipotriene plus betamethasone dipropionate gel/suspension for 4-12 weeks in scalp psoriasis 2. This recommendation is based on multiple RCTs showing 67-70% of patients achieved clear or almost clear scalp psoriasis at 8 weeks 2. The combination product demonstrated superior efficacy compared to either agent alone 2.
Important Clinical Caveats
Timing Restrictions
- Avoid application within 12 hours before or after chemical hair treatments (perms, relaxers, dyes) 1
- Apply after phototherapy sessions if combining treatments, as UV radiation can inactivate calcipotriene 2
Areas to Avoid
- Do not use on face, underarms, groin, or eyes 1
- If accidental contact occurs, wash area immediately 1
Safety Monitoring
For adolescents with extensive scalp involvement (≥20% of scalp), one study reported mild adrenal suppression in 1 of 31 patients at week 4, which resolved after discontinuation 3. While generally well-tolerated, monitor for signs of HPA axis suppression with extensive use 1.
Long-term Use
A 52-week study demonstrated that 69-74% of patients maintained clear or almost clear status with once or twice daily application, with no serious adverse events including striae or HPA axis suppression 2. However, the standard recommendation remains 4-12 weeks for acute treatment 2.